Study on the Safety and Effectiveness of Terbinafine Solution for Treating Mild to Moderate Nail Fungus in Children Aged 6-17 Years
- Substances:–
Denmark- Participants:0–17 years
- Sponsor:Moberg Pharma AB (publ)
Rare diseases
Investigational molecules
Locations
Gustavslundsvagen 42 Tr 5, Vasterled, 167 51, Sweden
Research activity is centred on distal subungual onychomycosis in children and adolescents, with attention to mild to moderate fungal infection of the nail and age-specific treatment needs in subjects aged 6-17 years.
The sponsor’s clinical interest is focused on external treatment for nail mycosis, with outcomes related to treatment success, mycological cure, clinical cure, and complete cure.
Clinical trials run by this sponsor – those enrolling participants first.
DenmarkIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.